Triumvira Immunologics Strengthens its Leadership Team with Three Accomplished Life Sciences…
Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors, today announced the strengthening of…
Read More...
Read More...